Oxford Nanopore Technologies (ONT) and its subsidiary Oxford Nanopore Diagnostics (OND) develop and manufacture market-leading nanopore-based next generation sequencing (NGS) technologies used across research, biopharma, and in-vitro diagnostics (IVD). The company's goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere.
